Jane E Johnson
Overview
Explore the profile of Jane E Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
5781
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhu M, Huang Y, Bender M, Girard L, Kollipara R, Eglenen-Polat B, et al.
Cancer Res
. 2021 Jan;
81(7):1813-1826.
PMID: 33495232
Small cell lung cancer (SCLC) is a pulmonary neuroendocrine cancer with very poor prognosis and limited effective therapeutic options. Most patients are diagnosed at advanced stages, and the exact reason...
12.
Roome R, Bourojeni F, Mona B, Rastegar-Pouyani S, Blain R, Dumouchel A, et al.
Cell Rep
. 2020 Nov;
33(8):108425.
PMID: 33238113
Anterolateral system neurons relay pain, itch, and temperature information from the spinal cord to pain-related brain regions, but the differentiation of these neurons and their specific contribution to pain perception...
13.
Vue T, Kollipara R, Borromeo M, Smith T, Mashimo T, Burns D, et al.
Glia
. 2020 Jun;
68(12):2613-2630.
PMID: 32573857
Glioblastomas (GBMs) are incurable brain tumors with a high degree of cellular heterogeneity and genetic mutations. Transcription factors that normally regulate neural progenitors and glial development are aberrantly coexpressed in...
14.
Mona B, Villarreal J, Savage T, Kollipara R, Boisvert B, Johnson J
Genes Dev
. 2020 Apr;
34(9-10):621-636.
PMID: 32241803
Peripheral somatosensory input is modulated in the dorsal spinal cord by a network of excitatory and inhibitory interneurons. PTF1A is a transcription factor essential in dorsal neural tube progenitors for...
15.
Poirier J, George J, Owonikoko T, Berns A, Brambilla E, Byers L, et al.
J Thorac Oncol
. 2020 Feb;
15(4):520-540.
PMID: 32018053
The outcomes of patients with SCLC have not yet been substantially impacted by the revolution in precision oncology, primarily owing to a paucity of genetic alterations in actionable driver oncogenes....
16.
Wang X, Hu R, Ding Q, Savage T, Huffman K, Williams N, et al.
Nat Commun
. 2019 Jul;
10(1):3201.
PMID: 31324758
Pulmonary neuroendocrine (NE) cancer, including small cell lung cancer (SCLC), is a particularly aggressive malignancy. The lineage-specific transcription factors Achaete-scute homolog 1 (ASCL1), NEUROD1 and POU2F3 have been reported to...
17.
Rudin C, Poirier J, Byers L, Dive C, Dowlati A, George J, et al.
Nat Rev Cancer
. 2019 Jun;
19(7):415.
PMID: 31175338
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
18.
Rudin C, Poirier J, Byers L, Dive C, Dowlati A, George J, et al.
Nat Rev Cancer
. 2019 Mar;
19(5):289-297.
PMID: 30926931
Small cell lung cancer (SCLC) is an exceptionally lethal malignancy for which more effective therapies are urgently needed. Several lines of evidence, from SCLC primary human tumours, patient-derived xenografts, cancer...
19.
20.
Pozo K, Minna J, Johnson J
Genes Dev
. 2018 Sep;
32(17-18):1266.
PMID: 30181362
No abstract available.